<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02820792</url>
  </required_header>
  <id_info>
    <org_study_id>Schulthess_Anä_8</org_study_id>
    <nct_id>NCT02820792</nct_id>
  </id_info>
  <brief_title>Non-Crossover Study of the LMA Protector Versus Ambu AuraGain</brief_title>
  <official_title>A Randomized Non-Crossover Study of the LMA ProtectorTM Versus Ambu Aura GainTM in Adult Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Schulthess Klinik</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Schulthess Klinik</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The LMA ProtectorTM is a new extraglottic airway device which brings together features of
      both the LMA ProSealTM (high seal cuff, gastric access and bite block - to facilitate
      ventilation, airway protection and airway obstruction, respectively) and the LMA UniqueTM
      (single use - prevention of disease transmission). In the following randomized study the
      investigators test the hypothesis that ease of insertion, oropharyngeal leak pressure,
      fiberoptic position and ease of gastric tube placement differ between the LMA ProtectorTM and
      the Ambu AuraGainTM in paralyzed, anesthetized patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Actual">December 20, 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>oropharyngeal leak pressure</measure>
    <time_frame>5 min</time_frame>
    <description>Oropharyngeal leak pressure was determined by closing the expiratory valve of the anesthesia breathing system and a fixed gas flow of 3 l minute-1. The airway pressure at which an equilibrium was reached was noted (maximum allowed 40 cm H2O).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>anatomic position</measure>
    <time_frame>5 min</time_frame>
    <description>The anatomic position was assessed by passing a fiberoptic scope through the airway tube stopping 0,5 cm prior to the end of the tube. The airway tube view was scored using an established scoring system.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Airway Morbidity</condition>
  <arm_group>
    <arm_group_label>LMA ProtectorTM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>function tests: ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ambu AuraGainTM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>function tests: ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>function tests</intervention_name>
    <description>function tests: ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion</description>
    <arm_group_label>LMA ProtectorTM</arm_group_label>
    <arm_group_label>Ambu AuraGainTM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LMA ProtectorTM</intervention_name>
    <arm_group_label>LMA ProtectorTM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ambu AuraGainTM</intervention_name>
    <arm_group_label>Ambu AuraGainTM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA 1 or 2

          -  Age 19-65 yr

          -  Written informed consent

        Exclusion Criteria:

          -  Difficult airway

          -  Non fasted

          -  BMI &gt; 35
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Berthold Moser, MD MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Schulthess Klinik</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Christian Keller MD, M.Sc.</name>
      <address>
        <city>Zürich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schulthess Klinik</name>
      <address>
        <city>Zürich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2016</study_first_submitted>
  <study_first_submitted_qc>June 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2016</study_first_posted>
  <last_update_submitted>January 25, 2017</last_update_submitted>
  <last_update_submitted_qc>January 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

